These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor. Patel S; Patel S; Marwood R; Emms F; Marston D; Leeson PD; Curtis NR; Kulagowski JJ; Freedman SB Mol Pharmacol; 1996 Dec; 50(6):1658-64. PubMed ID: 8967990 [TBL] [Abstract][Full Text] [Related]
23. Discovery and pharmacological characterization of a small-molecule antagonist at neuromedin U receptor NMUR2. Liu JJ; Payza K; Huang J; Liu R; Chen T; Coupal M; Laird JM; Cao CQ; Butterworth J; Lapointe S; Bayrakdarian M; Trivedi S; Bostwick JR J Pharmacol Exp Ther; 2009 Jul; 330(1):268-75. PubMed ID: 19369576 [TBL] [Abstract][Full Text] [Related]
24. Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s). Zgombick JM; Borden LA; Cochran TL; Kucharewicz SA; Weinshank RL; Branchek TA Mol Pharmacol; 1993 Sep; 44(3):575-82. PubMed ID: 8396718 [TBL] [Abstract][Full Text] [Related]
25. Characterization of the rat uterine neuromedin U receptor. Nandha KA; Benito-Orfila MA; Smith DM; Bloom SR Endocrinology; 1993 Aug; 133(2):482-6. PubMed ID: 8393763 [TBL] [Abstract][Full Text] [Related]
26. Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias. Shetzline SE; Rallapalli R; Dowd KJ; Zou S; Nakata Y; Swider CR; Kalota A; Choi JK; Gewirtz AM Blood; 2004 Sep; 104(6):1833-40. PubMed ID: 15187020 [TBL] [Abstract][Full Text] [Related]
27. Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells. Linden J; Thai T; Figler H; Jin X; Robeva AS Mol Pharmacol; 1999 Oct; 56(4):705-13. PubMed ID: 10496952 [TBL] [Abstract][Full Text] [Related]
28. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor. Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Bruinvels AT; Geisse S; Sommer B; Hoyer D; Tricklebank M; Schoeffter P Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773 [TBL] [Abstract][Full Text] [Related]
29. Identification of non-peptidic neuromedin U receptor modulators by a robust homogeneous screening assay. Meng T; Su HR; Binkert C; Fischli W; Zhou L; Shen JK; Wang MW Acta Pharmacol Sin; 2008 Apr; 29(4):517-27. PubMed ID: 18358099 [TBL] [Abstract][Full Text] [Related]
30. [Activating effect of citrus flavonoids on neuromedin U2 receptor and analysis on siRNA interference]. Wang DQ; Zheng XX; Yin ZY; Guo LX; Deng XH; Chen G Zhongguo Zhong Yao Za Zhi; 2012 Nov; 37(22):3462-6. PubMed ID: 23373222 [TBL] [Abstract][Full Text] [Related]
31. Identification and characterization of two neuromedin U receptors differentially expressed in peripheral tissues and the central nervous system. Raddatz R; Wilson AE; Artymyshyn R; Bonini JA; Borowsky B; Boteju LW; Zhou S; Kouranova EV; Nagorny R; Guevarra MS; Dai M; Lerman GS; Vaysse PJ; Branchek TA; Gerald C; Forray C; Adham N J Biol Chem; 2000 Oct; 275(42):32452-9. PubMed ID: 10899166 [TBL] [Abstract][Full Text] [Related]
32. Chemical genetic analysis reveals the effects of NMU2R on the expression of peptide hormones. Fang L; Zhang M; Li C; Dong S; Hu Y Neurosci Lett; 2006 Aug; 404(1-2):148-53. PubMed ID: 16781063 [TBL] [Abstract][Full Text] [Related]
33. Characterization of ligand-binding properties and selectivities of three rat tachykinin receptors by transfection and functional expression of their cloned cDNAs in mammalian cells. Ingi T; Kitajima Y; Minamitake Y; Nakanishi S J Pharmacol Exp Ther; 1991 Dec; 259(3):968-75. PubMed ID: 1662278 [TBL] [Abstract][Full Text] [Related]
34. Expression of NMS and NMU2R in the pig reproductive axis during the estrus cycle and the effect of NMS on the reproductive axis in vitro. Yang G; Su J; Li X; Yao Y; Lei Z; Yang X; Kou R; Liu Y Peptides; 2009 Dec; 30(12):2206-12. PubMed ID: 19781586 [TBL] [Abstract][Full Text] [Related]
35. Heterologous expression of human Neuromedin U receptor 1 and its subsequent solubilization and purification. Xia H; Liu L; Reinhart C; Michel H Biochim Biophys Acta; 2008 Oct; 1778(10):2203-9. PubMed ID: 18598671 [TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and biological activity of flavonoid derivatives as selective agonists for neuromedin U 2 receptor. Ma ML; Li M; Gou JJ; Ruan TY; Jin HS; Zhang LH; Wu LC; Li XY; Hu YH; Wen K; Zhao Z Bioorg Med Chem; 2014 Nov; 22(21):6117-23. PubMed ID: 25262941 [TBL] [Abstract][Full Text] [Related]
37. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28. Panetta R; Greenwood MT; Warszynska A; Demchyshyn LL; Day R; Niznik HB; Srikant CB; Patel YC Mol Pharmacol; 1994 Mar; 45(3):417-27. PubMed ID: 7908405 [TBL] [Abstract][Full Text] [Related]
38. Purification and identification of neuromedin U as an endogenous ligand for an orphan receptor GPR66 (FM3). Kojima M; Haruno R; Nakazato M; Date Y; Murakami N; Hanada R; Matsuo H; Kangawa K Biochem Biophys Res Commun; 2000 Sep; 276(2):435-8. PubMed ID: 11027493 [TBL] [Abstract][Full Text] [Related]
39. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Frucht H; Gazdar AF; Park JA; Oie H; Jensen RT Cancer Res; 1992 Mar; 52(5):1114-22. PubMed ID: 1310640 [TBL] [Abstract][Full Text] [Related]
40. The neuropeptide neuromedin U promotes inflammation by direct activation of mast cells. Moriyama M; Sato T; Inoue H; Fukuyama S; Teranishi H; Kangawa K; Kano T; Yoshimura A; Kojima M J Exp Med; 2005 Jul; 202(2):217-24. PubMed ID: 16009716 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]